Substance Use Disorders Notable Among Adult Cancer Survivors
January 19th 2024Investigators indicate that ongoing efforts should focus on meeting the needs of adult cancer survivors with co-morbid substance use disorder, with an emphasis on prioritizing populations in which the disorder is highly present.
Efficacy Improvement Observed in Nivolumab Combo in Advanced GI Cancers
January 18th 2024Results from an observational study found nivolumab plus chemotherapy helped enhance overall survival and progression-free survival for patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma.
Real-World Data Highlight Male Breast Cancer Population Outcome Disparities
January 15th 2024Black male patients with breast cancer appear to experience worse survival outcomes compared with White patients when controlling for clinicopathological variables, according to Jason (Jincong) Q. Freeman, MPH, MS.
Pembrolizumab/Chemoradiotherapy Approval is ‘Huge Win’ in Cervical Cancer
January 12th 2024Jyoti S. Mayadev, MD, says that pembrolizumab in combination with chemoradiation will be seamlessly incorporated into her institution’s treatment of those with FIGO 2014 stage III to IVA cervical cancer following the regimen’s FDA approval.